Antigen production, formulation and fill suites proven before a pandemic-speed campaign
Commissioning, qualification and validation software for vaccine facilities where antigen production bioreactors, inactivation skids, formulation suites and fill lines all have to qualify against compressed timelines without cutting evidence.
Vaccine manufacturing spans antigen production, inactivation or attenuation, formulation and often high-speed fill-finish, frequently under pandemic-response timelines where the CQV programme is compressed but the evidence bar does not move. Deskely holds every bioreactor, inactivation skid, formulation vessel and fill line asset in one register with IQ, OQ, PQ and biosafety containment gates built in.
- Assets
- Bioreactors, inactivation skids, formulation vessels
- Test
- IQ, OQ, PQ, biosafety containment verification
- Environment
- BSL-2/3 containment, grade A/B fill zones
- Gate
- Rapid GMP campaign start
Choose your project type
The problem
A pandemic-speed timeline compresses months into weeks, and a spreadsheet cannot compress with it without losing the evidence trail.
Vaccine facilities frequently run antigen production, inactivation and formulation in parallel workstreams with fill-finish qualified simultaneously, often under compressed timelines that leave no room for reconstructing evidence after the fact.
When bioreactor qualification, biosafety containment verification and formulation vessel records sit in separate accelerated-programme trackers, nobody can confirm which workstream is actually gating the overall campaign start.
Deskely tags every bioreactor, inactivation skid, formulation vessel and containment boundary individually, so a compressed programme still produces a complete, traceable evidence set rather than a rushed summary.
Setting up the register
Antigen, inactivation and formulation assets are tagged and templated in parallel to compress the schedule without compressing the evidence.
Process flow diagrams and containment drawings are parsed into a reviewed register across every workstream simultaneously, so bioreactors, inactivation skids and formulation vessels all carry their URS and vendor data from day one.
IQ, OQ and PQ protocols are templated once per equipment type and instantiated in parallel across workstreams, letting antigen production, inactivation and fill-finish teams execute qualification concurrently against a shared register.
Biosafety containment verification — BSL-2/3 boundary integrity, HEPA filtration and effluent decontamination — is held as its own record type against the containment zone, tracked alongside equipment qualification rather than as an afterthought.
Execution
Parallel qualification across production, inactivation and fill is gated per workstream so one delay does not block the others unnecessarily.
Bioreactor and inactivation skid OQ, formulation vessel qualification and fill line commissioning run in parallel tracks, each with its own readiness status visible without waiting on the others to complete.
Biosafety containment testing is executed against every BSL boundary and effluent system before inactivated or live material can move between zones, with results logged against the specific containment tag.
Deviations across any workstream are logged at the specific asset, so campaign leadership can see in real time which single item is actually the critical path rather than guessing from status meetings.
Rapid campaign start with full traceability
The campaign starts as fast as the evidence allows, with every record signed and traceable even under a compressed timeline.
Campaign readiness draws on the qualification status of every workstream simultaneously, so the evidence a quality unit needs for an emergency use authorisation or standard approval pathway is an export, not a last-minute compilation under time pressure.
The handover pack for manufacturing includes as-built process flows, containment verification and qualification summaries across every workstream, keyed to the register built during the compressed programme.
Every signature carries a name, role and timestamp, which is what a regulator reviewing an accelerated approval pathway and the site's own quality unit expect regardless of how compressed the underlying timeline was.
Strain or antigen change-over
A new antigen or strain enters the same qualified train, and a compressed seasonal timeline still has to prove the train performs on the new material before release.
Seasonal and pandemic-response vaccine manufacturing frequently reuses a qualified bioreactor and formulation train for a new antigen or strain rather than building a new facility, which means requalification work has to be scoped precisely: what genuinely changes with the new material, and what evidence from the previous strain's qualification still applies.
Doing that scoping from scratch on every strain change, under a compressed release timeline, tends to produce one of two failure modes: over-testing everything because nobody can confirm what is unaffected, or under-testing because the deadline pressure wins the argument.
Deskely carries the prior strain's qualification record against the same equipment tags, so a strain change-over review starts from what is already proven — vessel integrity, automation recipe, CIP/SIP performance — and scopes new PQ and potency-relevant testing only to what the new antigen actually changes.
The vaccine dossier
The record set behind a facility that has to scale from antigen to filled dose without a gap.
Vaccine manufacture spans upstream antigen production, inactivation or adjuvant blending and fill-finish, often under biosafety containment. The dossier links containment, inactivation and multi-suite segregation evidence to the qualification records that let a facility run several products without cross-contamination.
Biosafety cabinet and containment suite qualification reports
Containment level equipment holds the airflow and filtration performance needed for the organism handled.
Before handling live or attenuated agents.
Inactivation and adjuvant blending process validation batches
Antigen inactivation and adjuvant mixing meet potency and safety specifications reproducibly.
Following equipment OQ and prior to PPQ.
Multi-product suite changeover cleaning validation results
Residual antigen from a prior campaign is cleared before the next product is introduced.
After each changeover cleaning cycle.
HEPA filter integrity and effluent decontamination verification
Exhaust air and liquid waste are rendered safe before release from containment.
Commissioning and scheduled requalification.
Cold chain temperature mapping reports for bulk antigen storage
Bulk drug substance is held within the stability-supported temperature range.
Qualification of storage areas and continuous monitoring.
CSV audit trail review for batch genealogy tracking system
Antigen lot, formulation and fill lot are linked without gaps in the electronic record.
System go-live and periodic Part 11 review.
How it runs
From parallel FAT to a rapid, fully traceable campaign start.
Vaccine programmes reward a register built to run every workstream in parallel, because compressed timelines cannot come at the cost of a defensible evidence trail.
- 01
Model every workstream at once
Antigen production, inactivation, formulation and fill modelled as parallel subsystems in a shared register.
- 02
Parse process and containment drawings
Process flows and containment boundaries drafted into the register with vendor data attached across every workstream.
- 03
Template qualification for concurrent execution
IQ/OQ/PQ protocols defined once per equipment type, instantiated in parallel across all workstreams simultaneously.
- 04
Gate the campaign on real-time critical path
Campaign readiness reported live across workstreams so the actual blocking item is visible immediately.
FAQ
Questions about Vaccine facilities scopes.
Keep reading
Life sciences and pharma commissioning
The full sector view: CQV strategy, the validation master plan and the terminology behind them.
Read moreCertificates
IQ, OQ, PQ and release-to-GMP certificates issued from signed, ALCOA+ records instead of a scanned binder.
Read moreITR records
IQ, OQ and PQ protocols defined once per equipment type and executed against every vessel, skid and room with a full audit trail.
Read moreOther life sciences project types: Sterile fill-finish CQV, Biologics drug substance CQV, Oral solid dose manufacturing CQV, Cell and gene therapy facility CQV, API and chemical synthesis facility CQV, Cleanroom and HVAC qualification, Clean utilities qualification — WFI, clean steam and process gases, Lab and R&D facility CQV, Cold chain and warehouse qualification.
